Study on the construction of tumor precision medication patterns - non small cell lung cancer TP regimen as an example

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040783

Enrollment

Unknown

Registered

2020-12-10

Start date

2017-09-05

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Case series:With chemotherapy regimen of paclitaxel and cisplatin.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Cytologically or histologically confirmed NSCLC; Aged 18-70 years old; With chemotherapy regimen of paclitaxel and cisplatin.

Exclusion criteria

Exclusion criteria: Transferred to another hopital or with incomplete medical information.

Design outcomes

Primary

Measure	Time frame
toxicity;response evaluation;	—

Countries

China

Contacts

Public ContactGuohui Li

Cancer Hospital, Chinese Academy of Medical Sciences

lgh0603@126.com+86 010-87788573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026